Treatment Persistence and Adherence Among Patients With Psoriatic Arthritis Who Initiated Targeted Immune Modulators in the US: A Retrospective Cohort Study.

Adv Ther · 2021 · PMC8107156 · PMID 33759081

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When using a fixed allowable gap of 90 days for all the targeted immune modulators, the mean duration of persistence remained longer for PsA patients who initiated an IL-12/23i versus a TNFi or tsDMARD, although the latter comparison did not reach statistical significance (Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.